AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO) committed to delivering the highest standard of service to its customers and partners. With a strong focus on quality, reliability, and innovation, AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics (from mammalian cell culture and microbial fermentation), plasmid DNA (pDNA), viral vectors, and cell therapies. The company supports clients from early-stage development through clinical trials to commercial manufacturing, aiming to accelerate their partners' journey to market with speed, efficiency, and a patient-centric approach. AGC Biologics operates multiple cGMP-compliant facilities in the United States, Europe, and Asia, offering a global network to meet diverse client needs.
Global corporate leadership, strategic planning, business development, and oversight of worldwide operations. The Bothell site also serves as a key hub for process development and cGMP manufacturing of mammalian-based biologics.
State-of-the-art cGMP manufacturing suites for mammalian cell culture, advanced process development laboratories, comprehensive analytical and quality control labs, and corporate administrative offices. Designed for flexible and scalable biopharmaceutical production, supporting clinical to commercial supply.
A science-driven, collaborative environment focused on innovation, quality, and customer satisfaction. Employees are dedicated to advancing patient treatments through cutting-edge biomanufacturing and a 'customer-first' mindset.
Serves as the central command for AGC Biologics' global network, driving strategic initiatives and ensuring consistent quality and service delivery across all sites. Its location in the vibrant Seattle biotech hub facilitates collaboration, talent acquisition, and innovation.
AGC Biologics supports global biopharmaceutical development and manufacturing through an extensive network of sites across North America (USA), Europe (Denmark, Germany, Italy), and Asia (Japan). This network provides comprehensive services including process development, clinical and commercial cGMP manufacturing of protein-based therapeutics (mammalian and microbial), plasmid DNA (pDNA), viral vectors for gene therapies, and cell therapies. Their integrated global operations ensure consistent quality, regulatory compliance (FDA, EMA, PMDA), and efficient technology transfer between sites, enabling them to serve a diverse international clientele from early-stage research and development through to full-scale commercial supply.
22021 20th Ave SE
Bothell
Washington
USA
Address: Vandtårnsvej 83A, DK-2860 Søborg, Denmark
Serves as a major hub for European and global clients, providing extensive expertise and capacity in microbial expression systems and supporting projects from clinical to commercial phases.
Address: Czernyring 22, 69115 Heidelberg, Germany
Strengthens AGC Biologics' European presence by providing specialized microbial fermentation capabilities and supporting clinical to commercial supply chains, particularly for the German and Central European biotech sector.
Address: Via Olgettina, 58, 20132 Milano MI, Italy
Pivotal site for AGC Biologics' advanced therapies business, serving global clients with cutting-edge solutions in the rapidly growing cell and gene therapy field, and acting as a hub for innovation in this area.
Address: 10 Goikaigan, Ichihara, Chiba 290-8566, Japan
Key facility for serving the Asian biopharmaceutical market, providing access to AGC Biologics' global standards and expertise in microbial systems and pDNA, supporting regional clients and global supply chains.
Address: 4000 Nelson Rd, Longmont, CO 80503, USA
Significantly expands AGC Biologics' commercial manufacturing capacity in North America, addressing the growing demand for large-scale biologic drug substance production and ensuring supply chain security for US-based clients.
Address: 5550 Airport Blvd, Boulder, CO 80301, USA
Complements the Longmont facility and Bothell HQ by offering flexible manufacturing solutions and additional capacity in the US, supporting a diverse range of biologic modalities.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AGC Biologics' leadership includes:
AGC Biologics has been backed by several prominent investors over the years, including:
In the past 12 months, AGC Biologics has experienced key changes in its operational leadership, notably appointing an interim COO for its US Operations following the departure of the previous Global COO. The company continues to strengthen its site leadership team with new General Manager appointments for its expanding Colorado facilities.
Discover the tools AGC Biologics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
AGC Biologics commonly utilizes email formats such as [first initial][last name]@agcbio.com (e.g., jsmith@agcbio.com) and [first name].[last name]@agcbio.com (e.g., john.smith@agcbio.com). These are standard corporate patterns that facilitate professional communication with company employees. Variations might exist depending on the region or specific business unit.
[first_initial][last]@agcbio.com or [first].[last]@agcbio.com
Format
jsmith@agcbio.com
Example
85%
Success rate
Business Wire • May 29, 2024
AGC Biologics announced the expansion of its cell therapy development capabilities at its Milan, Italy facility. This includes new R&D labs and services to support early-phase development of cell-based therapies, enhancing their end-to-end cell therapy offerings....more
Business Wire • May 16, 2024
AGC Biologics has appointed Scott Liebler as Interim Chief Operations Officer (COO) for its US Operations. Liebler brings extensive experience in biopharmaceutical manufacturing and operations leadership to support AGC Biologics' facilities in Bothell, WA, and Boulder & Longmont, CO....more
Business Wire • April 9, 2024
AGC Biologics announced a strategic alliance with BioConnection, a Dutch CDMO, to provide its customers with aseptic drug product fill/finish services. This partnership expands AGC Biologics' end-to-end service offerings by integrating downstream fill/finish capabilities....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AGC Biologics, are just a search away.